Feedback / Questions
AFTX-201 - Affinia Therap
https://www.businesswire.com/news/home/20250428032612/en/Affinia-Therapeutics-to-Present-New-Data-on-its-AFTX-201-Program-in-BAG3-Dilated-Cardiomyopathy-BBB-Penetrant-AAV-Capsids-and-Proprietary-Manufacturing-Technology-at-the-28th-Annual-American-Society-of-Gene-Cell-Therapy-2025-Annual-Meeting
Apr 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next